- UPDATE - Russia's EpiVacCorona Drug Fully Suitable for Re-Vaccination Against COVID-19 - Developer
UPDATE - Russia's EpiVacCorona Drug Fully Suitable For Re-Vaccination Against COVID-19 - Developer
Muhammad Irfan 12 days ago Thu 08th April 2021 | 08:20 AM
MOSCOW (UrduPoint News / Sputnik - 08th April, 2021) Russia's EpiVacCorona vaccine is fully suitable for the re-vaccination against COVID-19, the director of the Vector research institute that developed the drug told Sputnik.
"The EpiVacCorona vaccine is fully suitable for the re-vaccination," Rinat Maksyutov said.
According to the institute's director, both doses of the EpiVacCorona vaccine are in fact the same drug.
"EpiVacCorona is a single-component vaccine, which is received by a patient twice with an interval of 21 days," Maksyutov said.